(Q30355798)

20 June 2017

Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant. (English)

1 reference

20 June 2017

0 references

Carolyn J Hutcheon

1

1 reference

20 June 2017

Jessica O Becker

2

1 reference

20 June 2017

Brett A Russell

3

1 reference

20 June 2017

Pauline A Bariola

4

1 reference

20 June 2017

Glenna J Peterson

5

1 reference

20 June 2017

Steven D Stroop

6

1 reference

20 June 2017

language of work or name

English

0 references

publication date

5 July 2006

1 reference

20 June 2017

1 reference

20 June 2017

24

1 reference

20 June 2017

49-50

1 reference

20 June 2017

7214-7225

1 reference

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Technologies for the design, discovery, formulation and administration of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Predicting the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Elutability of Proteins from Aluminum-Containing Vaccine Adjuvants by Treatment with Surfactants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Effect of pH on the Elution of Model Antigens from Aluminum-Containing Adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Multiple unfolding intermediates of human placental alkaline phosphatase in equilibrium urea denaturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

Low pH-induced conformational changes in vesicular stomatitis virus glycoprotein involve dramatic structure reorganization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.043

10.1016/J.VACCINE.2006.06.043

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference